1. Home
  2. Events
  3. The 5th Kyoto University LifeScience Showcase @San Diego 2024

Registration

The 5th Kyoto University LifeScience Showcase @San Diego 2024

The 5th Kyoto University LifeScience Showcase @San Diego 2024 is designed to be of particular interest to the Angel, Family Office and VC investor communities, and potential strategic alliance partners, the Showcase will feature face-to-face presentations from 11 selected Life Science companies from Japan, US and Taiwan seeking funding and strategic alliances. Progenicyte Japan Co., Ltd. will participate from Kobe Biomedical Innovation Cluster (KBIC).

Please review the event information below and register at your earliest opportunity.

The 5th Kyoto University LifeScience Showcase @San Diego 2024

Registration: https://sites.google.com/kuhp.kyoto-u.ac.jp/kuls2024

Date and Time
February 26, 2024 1-4:30pm (PST)
Venue
Roth Auditorium at Sanford Consortium for Regenerative Medicine
2880 Torrey Pines Scenic Drive, La Jolla, CA 92037 Map
*Live streaming will be available for the US domestic residents only.
Registration is required if you wish to watch live streaming.
Participation Fee
Free of charge

Start-ups stemming from Japanese academia who have state-of-the-art innovations with solid science and technologies will participate in the event and present their novel technologies and seeds in the life science fields including immunology and infectious diseases, medical devices, small molecule therapeutics and regenerative medicine.
Participants who are interested in investing in medical area innovations will be welcomed.

We look forward to having you join us on Monday, February 26!

Details and Registration
Registration

Program

1:00pm(PST) Showcase pitch event
4:30pm(PST) Networking & reception
6:00pm(PST) Adjourn

Presenters

*The detailed program will be announced later.

AquaAge Inc.
"Skin Image Analysis of AquaAge Inc."
EverFortune.AI
"AI-Powered Organ-Specific Clinical Solutions and Hyper-Efficient Deep Data Chips"
Ever Supreme Bio Technology
"Allogenic cell therapy for solid tumors: An innovative CAR-T strategy"
Eyegenex, Inc
"Gene therapy for the treatment of glaucoma." 
FeropptoCure Inc.
"World’s 1st Ferroptosis inducing Anti-cancer therapeutics"
MeLoD Co., Ltd.
"Multidisciplinary discussion (MDD) Diagnosis system for Interstitial Pneumonia Disease(ILD)"
Progenicyte Japan Co., Ltd.
"Custom exosome production service"
SCM BioMedica Co., Ltd.
"Development of innovative cancer immunotherapy harnessing PD-1 immune checkpoint inhibitors" 
Spine Chronicle Japan
"The best spinal implant for aging spine" 
Surv BioPharma Inc.
"Gene therapy for cancer: Oncolytic Virus "Surv.m-CRA-1"